# Comparison of Hemanext ONE® System and Conventional Red Blood Cell Transfusion

> **NCT06685848** · NA · RECRUITING · sponsor: **Hemanext** · enrollment: 24 (estimated)

## Conditions studied

- Hematologic Neoplasms

## Interventions

- **DEVICE:** Hemanext ONE system
- **DEVICE:** Conventional RBCs

## Key facts

- **NCT ID:** NCT06685848
- **Lead sponsor:** Hemanext
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-29
- **Primary completion:** 2026-12-15
- **Final completion:** 2026-12-15
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06685848

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06685848, "Comparison of Hemanext ONE® System and Conventional Red Blood Cell Transfusion". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06685848. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*